Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
목요일, 9월 03

Purple Biotech Ltd

PPBTNASDAQ
Trade with Public
Trade with Public
$1.98
0.3219.28%
가까이에: Sep 1, 5:00 PM EST
$1.84
0.1810.84%
프리마켓: 6:01 AM EST
PRO
변동 이유?:Purple Biotech shares are trading higher after the company announced the U....
개요뉴스실적 전망이벤트목표가재무심리비교옵션주식 보고서

Purple Biotech Financials

Purple Biotech (PPBT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
CORRECTION: Purple Biotech Q2 EPS $(0.41) Beats $(0.98) Estimate

Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.98) by 58.16 percent. This is a 89.75 percent increase over losses of $(4.00) per share from
Benzinga Newsdesk

PRO
CORRECTION: Purple Biotech Q1 EPS $(0.09) Beats $(1.06) Estimate

Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(1.06) by 91.51 percent. This is a 94.71 percent increase over losses of $(1.70) per share from
Benzinga Newsdesk

Earnings Scheduled For May 15, 2026

Benzinga Insights

PRO
Purple Biotech Q4 EPS $19.85 Beats $(3.40) Estimate

Purple Biotech (NASDAQ:PPBT) reported quarterly earnings of $19.85 per share which beat the analyst consensus estimate of $(3.40) by 683.82 percent. This is a 863.46 percent increase over losses of $(2.60) per share from
Benzinga Newsdesk

PRO
Purple Biotech Q3 EPADS $(0.29) Misses $(0.26) Estimate

Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.26) by 11.54 percent. This is a 25.64 percent increase over losses of $(0.39) per share from
Benzinga Newsdesk

Dow Surges 250 Points; Verizon Posts Mixed Q3 Results

Avi Kapoor

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved